Terra Wonsettler, PharmD, MBA, Vice President of Clinical Evidence, Policy, and Oncology Pharmacy at Evolent, discusses the cardiotoxicity of many cancer drugs, cancer patient awareness of these risks, and the accelerated cancer drug approval process.